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Available online 6 February 2016Formalin-ﬁxedparafﬁn-embedded (FFPE) tissue is awidely available clinical specimen for retrospective studies. The
possibility of long-term clinical follow-up of FFPE samples makes them a valuable source to evaluate links between
molecular and clinical information. Working with FFPE samples in the molecular research area, especially using
high-throughputmolecular techniques such asmicroarray gene expression proﬁling, has come into prominence. Be-
cause of the harmful effects of formalin ﬁxation process such as degradation of nucleic acids, cross-linkingwith pro-
teins, and chemical modiﬁcations on DNA and RNA, there are some limitations in gene expression proﬁling studies
using FFPE samples. To date many studies have been conducted to evaluate gene expression proﬁling using micro-
arrays (Thomas et al., Thomas et al. (2013) [1]; Scicchitano et al., Scicchitano et al. (2006) [2]; Frank et al., Frank et al.
(2007) [3]; Fedorowicz et al., Fedorowicz et al. (2009) [4]). However, there is still no generally accepted, efﬁcient and
standardized procedure formicroarray analysis of FFPE samples. This paper describes themicroarray data presented
in our recently accepted to be published article showing a standard protocol from deparafﬁnization of FFPE tissue
sections and RNA extraction tomicroarray gene expression analysis. Herewe represent our data in detail, deposited
in the gene expression omnibus (GEO) database with the accession number GSE73883. Four combinations of two
different cRNA/cDNA preparation and labeling protocols with two different array platforms (Affymetrix Human
Genome U133 Plus 2.0 and U133_X3P) were evaluated to determine which combination gives the best percentage
of present call. The study presents a dataset for comparative analysis which has a potential in terms of providing a
robust protocol for gene expression proﬁling with FFPE tissue samples.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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featuresFour 8-μm-thick colon parafﬁn-embedded tissue sections
were used for RNA extractions. Four different hybridization
combinations were performed on four labeled samples using
two different kits (Affymetrix 3′ IVT kit and the NuGEN Ova-
tion FFPE WTA system) and two different arrays (Humantechnology Institute, 06100,
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four samples have matched control samples. Gene expression
data analysis was also performed for these three matched
samples. Totally, this dataset includes 19 arrays.onsent Informed consent was obtained from all patients.
mple source
locationAnkara University, Faculty of Medicine, Department of
Pathology, Ankara, Turkey1. Direct link to deposited data
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2. Experimental design, materials and methods
2.1. Experimental design
A comparison studywas conducted assessing two differentmicroar-
ray chips and ampliﬁcation kits for performance comparison. All steps
are represented in Fig. 1.se (http://creativecommons.org/licenses/by-nc-nd/4.0/).
304 N. Belder et al. / Genomics Data 7 (2016) 303–306RNA was extracted from four sporadic colorectal cancer FFPE sam-
ples usingQiagen RNeasy extraction kitwithmodiﬁed deparafﬁnization
step. The yield and quality of RNA samples were evaluated using a
Nanodrop Spectrophotometer and a Agilent 2100 Bioanalyzer. We
assessed microarray performance by comparing four combinations of
two different cDNA preparation & labeling protocols and microarray
chips. Finally, gene expression data analysis was performed for three
matched samples using U133 X3+NuGEN Ovation FFPE WTA System
combination.
2.2. FFPE tissue materials
FFPE tissue samples were obtained from four colon adenocarcinoma
patients. Local ethical approval was obtained for using the humanmate-
rial (Research Ethics Committee ofMedical Faculty of Ankara University,
Ankara Ref: 153-4854). Four different 6–10 year old FFPE blocks were
used in this study (08/40 T(TT01), 08/95 T(TT08), 09/137 T(TT24) and
10/12 T(TT31)were collected in 2007, 2005, 2009, and 2006 respective-
ly). Three of these four samples have matched control samples (08/40
T(NT01), 08/95 T(NT08) and 10/12 T(NT31)).
2.3. Characteristics of patients
Four tumor samples and three matched controls of these four sam-
ples were used for microarray analysis. All cases were sporadic colorec-
tal cancers from female patients within the age of 27 to 48 years. The
histotype of the tumorswas conventional adenocarcinoma. The patients
had stage III disease and 75% of the patients have left colon sided. All
clinico-pathological parameters of the patients are given in Table 1.
2.4. Preparation of FFPE tissue samples and RNA extraction
All stepswere performed under RNase-free conditions. Four of 8 μm-
thick sections were cut from FFPE blocks, on a microtome with aFig. 1. A schematic representation ofdisposable blade. Two of the sections were placed on per microscope
slide. The tumor area containing ~90% tumor cells was used for
macrodissection.
Four sections were used for RNA extraction. Total RNA was isolated
using Qiagen RNeasy FFPE kit (Qiagen, Hilden, Germany) according to
the manufacturers' instructions except deparafﬁnization step. The
deparafﬁnization step was optimized by comparing our laboratory
deparafﬁnizationprotocolwithQiagenRNeasy FFPEkit's deparafﬁnization
step. These comparisons and their results were given in detail in our
manuscript accepted to be published in Pathology Research and Practice
[5]. RNA samples extracted from FFPE tissues were analyzed in terms of
RNA concentration and purity using NanoDrop ND-1000 Spectrophotom-
eter (NanoDrop Technologies, Wilmington, DE, USA).
The quality of RNA sampleswas assessedwith RNA6000NanoAssay
on Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA).
RNA degradation degree assessment was also checked with PCR which
was performed by amplifying seven different amplicon sets that
produced fragments ranging from 101 to 246 bp (B2M-101 bp, HPRT-
113 bp, VEGFA-168 bp, MAPK14-198 bp, TCF19-201 bp, TGFB1-
240 bp, NCAPG-246 bp).
2.5. In vitro transcription, ampliﬁcation, labeling and hybridization for gene
expression analysis
The RNA samples extracted from FFPE samples were ampliﬁed and
labeled using the 3′ IVT kit (Affymetrix, Santa Clara, CA) and theOvation
FFPEWTA System (NuGEN San Carlos, CA, USA). Human Genome U133
Plus 2.0 and U133_X3P arrays were used for hybridization. Four combi-
nations were used to determine which pairwise combination gives the
best result in terms of percentage of present call.
Four combinations depicted in Table 2 were applied on the four
tumor samples. One of these four combinations was applied on the
matched normal samples of three of the four samples. In the combina-
tionswhere 3′ IVT kit (Affymetrix, USA) is usedmanufacturer's protocolentire experimental workﬂow.
Table 1
Clinicopathological features of four colorectal cancer patients.
Sample name Tissue Age Gender Histology Tumor location Grade Stage
TT01 tumor_08/40 Colorectal FFPE 26 Female Adenocarcinoma Right sided colon Grade III Stage IIIB
TT08 tumor_08/95 Colorectal FFPE 46 Female Adenocarcinoma Left sided colon Grade II Stage IIIB
TT24 tumor_09/137 Colorectal FFPE 32 Female Adenocarcinoma Left sided colon Grade I Stage IIIB
TT31 tumor_10/12 Colorectal FFPE 48 Female Adenocarcinoma Left sided colon Grade II Stage IIIB
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od for ampliﬁcation process. In the combinations where Ovation FFPE
WTA System (NuGEN San Carlos, CA, USA) is used manufacturer's pro-
tocol was followed for the ampliﬁcation and labeling steps except for
the fragmentation performed from 3.5 μg of input cDNA instead of 4–
5 μg recommended in Nugen Ovation FFPE WTA System user guide.
The starting RNA amount for cDNA synthesis, the hybridized cRNA
(Affymetrix) and cDNA (Nugen) amount and hybridization conditions
are given in Table 2. For all four combinations the arrays were washed
and stained using user-prepared wash and stain reagents as speciﬁed
in the Affymetrix GeneChip® Expression Wash, Stain and Scan User
Guide (P/N 702731 Rev. 4, pp. 14–20). Gene Chips Fluidics Station 450
is used for thewash and stain step. The hybridized arrays were scanned
by a GeneChip Scanner 3000 7G and images were generated using
Affymetrix GeneChip Command Console (AGCC) program.
2.6. Statistical data analysis
Two different ampliﬁcation kits and two different Affymetrix micro-
array platforms were combined separately for four samples and perfor-
mance comparison was performed for each pairwise comparison. InTable 2
Data ﬁle names and combinations of four colorectal cancer patients and three matched controaddition, we had three samples that were the matched controls of
four samples. These threematched normal controlswere independently
isolated with Qiagen RNeasy FFPE kit, ampliﬁed, fragmented and la-
beled using Nugen Ovation FFPEWTA System for another larger micro-
array gene expression study. These samples were also hybridized to
U133_X3P Array. Gene expression microarray analysis was carried out
for three matched tumor and control samples. Totally, our GEO entry
has raw data for 19 arrays and 11 of them are for U133_X3P Array and
8 of them are for U133 Plus 2.0. The entire microarray data set has
been deposited at the Gene Expression Omnibus (GEO) database with
Accession Number GSE73883.
All of the raw data (CEL ﬁles) were preprocessed using
AffymetrixGeneChip Command Console software (version 3.0.1). The
percentage present calls were generated with Affymetrix MAS 5.0 ex-
pression algorithm. Group comparisons were performed using
Student's t test and one-way ANOVA. All analyses were implemented
using IBM SPSS Statistics version 20. A p b 0.005 was considered as sta-
tistically signiﬁcant.
Partek Genomic Suite 6.6 software (Partek Inc., St. Louis, MO, USA)
was used for paired three tumor and control sample gene expression
data analysis. Array data ﬁles with a .CEL extension were preprocessedl samples.
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multiarray averaging (RMA). Paired t test was performed to identify
differentially expressed genes. Fold-change values of−2 to 2 at a false
discovery rate of ≤5% and p-value cutoff of 0.001were used as a ﬁltering
criteria to ﬁnd statistically signiﬁcantly expressed genes. We then
performed unsupervised hierarchical cluster analysis for signiﬁcant
504 differentially expressed genes to visualize patterns of expression
in tumor and control samples. Euclidean distance and average linkage
algorithm were used for clustering in the Partek Genomic Suite.
3. Discussion
Here, we provide detailed description of methods for ourmicroarray
optimization and comparison study to help reusing of microarray data
obtained from FFPE extracted RNA. We believe that our conducted
workﬂow is useful and generally applicable to produce reliable gene
expression data from FFPE extracted RNA. These results highlight that
FFPE samples can be used as an alternative material to FF tissues for mi-
croarray gene expression studies. The entire results were also published
in our recent accepted manuscript [5].
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